Lexeo Therapeutics Ratios (2022-2026) | LXEO

1Y3Y5Y7Y10YAll
Download Data
Ratios Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -3,211.86%
EBIT Margin (Quarter) -3,292.28%
EBITDA Margin (Quarter) -3,292.28%
Operating Margin (Quarter) -3,292.28%
Net Margin (Quarter) -3,211.86%
Efficiency
Assets Average (Quarter) 97.27M176.51M202.61M182.94M160.40M136.32M150.88M159.96M206.27M259.52M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -64.75-379.93-35.20-27.56-2.25-299.48-1.28-1.34-5.71-51.47-63.42-3.32-2.49-42.65-8.09
Times Interest Earned (Quarter) -64.75-379.93-35.20-27.56-2.25-299.48-1.28-1.34-5.71-51.47-63.42-3.32-2.49-42.65-8.09
Valuation
Enterprise Value (Quarter) -94.15M-77.33M-35.45M-121.47M-195.06M-174.98M-157.00M-121.52M-99.83M-132.89M-122.76M-181.77M-193.04M
Return Ratios
Return on Sales (Quarter) -0.32%
Return on Capital Employed (Quarter) -85.61%-46.82%-44.68%-59.80%-76.89%-110.23%-103.46%-79.56%-57.67%-39.86%
Return on Assets (Quarter) -0.01%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%0.00%0.00%